UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) NOVEMBER 7, 2007
HANMI FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-30421
|
|
95-4788120 |
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.) |
|
|
|
3660 Wilshire Boulevard, Los Angeles, California
|
|
90010 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
Registrants telephone number, including area code (213) 382-2200
NA
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers.
On November 7, 2007, the Board of Directors of Hanmi Financial Corp. designated Dr. Sung Won
Sohn, its current President and Chief Executive Officer, to serve as interim principal financial
officer pending the appointment of a permanent principal financial officer. Information pertaining
to Dr. Sohn is set forth in the Companys proxy statement filed with the Securities and Exchange
Commission on April 20, 2007 (File No. 000-30421) under the heading Directors and Executive
Officers and is incorporated herein by reference.
2